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A novel synthesis of 1,2-disubstituted 1,2-dihydroquinazoline 3-oxides 8 and the first ever examples of 1,3-dipolar
trapping of these nitrones to homonuclear dipolarophiles is described. The new dipoles 8 reacted with N-methyl
maleimide, generating diastereomeric adducts 14–16. In the reaction between 8 and dimethyl acetylenedicarboxylate,
primary cycloadducts 17 and/or stable rearrangement products, azomethine ylides 18, are formed depending on the
substitution pattern of the dipole. The structure of 18c is unambiguously assigned by X-ray crystallographic analysis.
An X-ray crystal structure determination is also presented for the cyclopropylisoxazoloquinazoline 22 formed by a
[3 + 2] addition of 8a to 21, the dimethyl acetylenedicarboxylate tetramer.
Introduction
In connectionwith our studies on the formation of nitrones from
oximes,1–3 we now report the preparation of 1,2-disubstituted
1,2-dihydroquinazoline 3-oxides from o-aminoarylaldoximes.
Prior to the current work there have been no reported exam-
ples of the formation of aldonitrones of the 1,2-dihydroquinazo-
line skeleton; however, several examples of related ketonitrones
and aminonitrones are known. Cyclocondensations between 2-
aminobenzo(aceto)phenone oximes and dichloroethyl ethers,4
chloroethylacetoacetate,5 ketones6 or aldehydes7,8 have furnished
variously substituted 1,2-dihydroquinazoline ketonitrones. The
1,2,5,6-tetrahydropyrimidine 3-oxides 1, monocyclic analogues
of quinazoline 3-oxides, have been prepared by cyclocondensa-
tion of b-benzylaminoketoximes with aldehydes.9
Corresponding aminonitrones have been formed from o-
aminobenzamidoximes by cyclocondensation either to imines
formed in situ upon reaction with an aldehyde10 or to transient
iminium ions generated by dehydrogenation [Hg(II), EDTA] of
a tertiary amine.11,12 The same laboratory have also reported
formation of the tricyclic N-oxides 3 with a perhydro-pyrido or
-pyrrolo ring fused to the 1,2-a edge of the quinazoline nucleus.
The cyclic nitrones were generated, in the presence of Hg(II)-
EDTA complex, from appropriately substituted benzaldoximes
in a type of intramolecular Mannich reaction,13–15 for some
substrates, e.g. 2, lactams 4 accompany the cyclic nitrones 3
as minor reaction products.
Results and discussion
Substrate preparation
The targeted o-aminobenzaldehydes 6a, b and c were prepared
by a nickel catalysed addition of the appropriate organozinc
reagent to 2,1-benzisoxazole 5 as described in the literature.16
The p-CNC6H4 analogue 6d was prepared in 77% yield in a
parallel manner. During the synthesis of 6c and 6d, by-products
isolated in 12 and 6% yield respectively are identified as the
4,4′-disubstituted biphenyl derivatives 9a and 9b.17
Reaction between the o-aminobenzaldehydes 6 and
NH2OH·HCl (C5H5N, EtOH, 80 ◦C, 12 h) proceeded smoothly
to afford the oximes 7 as single geometrical isomers in
solution in CDCl3. Oximes 7a, b and d were isolated in
good yields as crystalline solids. The yield of 7c was some-
what lower with the desired oxime (60%) being accompa-
nied by 2-methoxyacridine (11%). The formation of both
2- and 4-methoxyacridine following TFA treatment of 2-
methoxydiphenylamine 2-carboxaldehyde 6c has previously
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been reported.16 It is likely that the pyridinium hydrochloride
generated during the oximation of 6c is responsible for inducing
cyclisation of unreacted aldehyde, so leading to the acridine by-
product.
Cyclocondensation of the o-aminobenzaldoximes 7a and b
with benzaldehyde was initially attempted under conditions
previously found to be successful for analogous amino oximes,
viz. fridge temperature in solution in Et2O/EtOH.10 However,
no reaction occurred between 7a and b and benzaldehyde at
4 ◦C. Upon heating the reactants in boiling EtOH, evidence
for the formation of 8a and b could be seen in the 1H
NMR spectrum of the crude reaction mixture; however, the
desired reaction was overshadowed by the formation of a
number of ethoxy addition products. Successful generation of
the quinazoline 3-oxides 8a–d resulted when the components
were heated at 80 ◦C using benzaldehyde (5 equiv.) as reactant
and solvent. Reaction duration and product yield varied with
the nature of the amino substituent. The N-methyl- and N-(p-
methoxyphenyl)-substituted substrates 7a and 7c reacted fastest
reaching completion after 16 h; the N-phenyl substrate 7b
required 72 h for full reaction whilst the p-cyanophenyl group on
7d significantly retarded progress and reaction had only reached
77% oxime conversion after 72 h. The quinazoline 3-oxides 8
were isolated by flash column chromatography.
In an effort to probe the probe the sensitivity of the reaction
to the nature of the aldehyde component, condensation be-
tween 2-(4-methoxyanilino)benzaldehyde oxime 7c and either p-
nitrobenzaldehyde or p-methoxybenzaldehyde was investigated.
Both nitrobenzaldehyde and the oxime remained solids at 80 ◦C
and 1H NMR spectral analysis confirmed that no reaction
occurred between the components at this temperature. At 120 ◦C
the reactants formed amolten solid, and following 4 h of heating
complete conversion to 8e was observed. The same oxime 7c
reacts with p-methoxybenzaldehyde rather sluggishly at 80 ◦C
and after 236 h 8f isolated in 49% yield, starting oxime was
recovered in 32% yield. Reaction progressed faster at 120 ◦C
having reached the same level of oxime conversion after 84 h,
when 1H NMR spectral data indicated a 1 : 2 mixture of oxime :
nitrone 7c : 8f.
In order to permit direct comparison between the nature of the
o-amino substituent on the oxime substrate 7 and the condensing
aldehyde, the reaction of 7c with benzaldehyde was repeated at
120 ◦C.After 6.5 h of heating almost quantative conversion to 8c
was found.Thus, as expected, themore electron-rich the o-amino
oxime substituent and the more electron-poor the condensing
aldehyde the faster the cyclocondensation reactions leading to 8.
Cycloaddition to quinazoline 3-oxides
The reactivity of 1,2-dihydroquinazoline 3-oxides has not been
extensively investigated. Aromatisation,18,19 ring expansion5,20
and hydrolysis6 of ketonitrones has been demonstrated, whilst
Dimroth rearrangements to isomeric 1,2-dihydro-4-quinaxolone
oximes are facile with aminonitrones.10 The trapping of 10a
with phenyl isocyanate represents the only reported example of
1,3-dipolar cycloaddition to 1,2-dihydroquinazoline-3-oxides.13
The same heterodipolarophile trapped the amidonitrone 10b 11
furnishing 11b. Aside from these two reactions there has
been no exemplification of the 1,3-dipolar character of the
1,2-dihydroquinazoline 3-oxide skeleton. However, a related
reaction is the trapping of the tetrahydropyrimidine N-oxide
12 with dimethyl acetylenecarboxylate (4 h, CHCl3), furnishing
13 (75%) as a single diastereomeric cycloadduct.9
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Reaction between the quinazoline 3-oxides 8 and N-methyl
maleimide proceeded under mild conditions (CH2Cl2, rt, 18 h)
to afford, with varying selectivity, diastereomeric cycloadducts
14–16. The relative stereochemistry of the adducts arising from
reaction of 8b was established by nuclear Overhauser effect
difference spectra (nOeds) studies and that of the others by
analogy.
The major diastereomer 14b (55%) displays a 3.6% enhance-
ment on the signal for H-11b following irradiation of H-11a, no
cross-ring enhancements between H-6 and any of H-8a, H-11a
or H-11b are found. The intermediate isomer 15b (35%) displays
a 2.8% enhancement on the signal representing H-11b following
irradiation of H-11a, and mutual cross-ring enhancements are
observed between H-6 and H-11b. The minor isomer 16b (10%)
shows no cross-ring enhancements between H-6 and any of H-
8a, H-11a or H-11b; however, there is an 8.5% enhancement
on the signal for H-11a following irradiation of H-11b. These
observations imply that the major product 14b is the product
of an exo-addition of the dipolarophile to the top face of
the dipole.† The intermediate adduct 15b arises from an exo-
addition of the dipolarophile to the lower face of the dipole. The
minor adduct 16b is a product of an endo-addition to the top
face of the dipole.
Within each family of diastereomeric cycloadducts 14–16a–e
a distinct pattern can be identified in the 1H NMR resonance
positions for the non-aromatic protons viz. H-6, H-8a, H-11a
and H-11b. Thus, for all the major adducts 14, H-11a resonates
between 3.77 and 3.84 ppm; H-11b resonates between 4.47 and
4.58 ppm; and H-8a resonates between 4.77 and 4.87 ppm.
For the adducts 15 the H-11b signal experiences a downfield
shift of ca. 0.7 ppm with respect to the corresponding signal
in the diastereomers 14. The proton with the most significant
difference in resonance position between adducts 14 and 16 is
H-11a which appears ca. 0.4 ppm downfield in the adducts 16
with respect to 14.
The similarity between the 1H NMR spectral data of the
adducts 14a,c–e, 15a,c–e and 16a,c–e with 14b, 15b and 16b
suggests that each diastereomer has a favoured conformation
in solution and permits extrapolation of the nOeds data
acquired for the latter to complete the assignment of the relative
stereochemistry of the former.
Reaction between the dipoles 8 and dimethyl acetylenedi-
carboxylate also proceeded to completion upon stirring an
equimolar ratio of the reactants in CH2Cl2 at rt for 18 h. The
reaction products varied with the nature of the N-1 substituent
on the dipole. All the N-1 aryl substrates 8b–e reacted to afford
primary cycloaddition products 17b–e, accompanied, in the
cases of 8b and 8c, by secondary products 18b,c. TheN-1 methyl
derivative 8a reacted rather differently.
† The 3-Si,4-Re face of the quinazoline 3-oxides is designated as the top
face.
Analysis of the 1H NMR spectral data of the crude mixture
following reaction between 8c and dimethyl acetylenedicar-
boxylate indicated the presence of two new reaction products.
Purification by flash column chromatography afforded pure
samples of each. The major product (32%), a red powder, was
characterised as the primary cycloaddition product 17c. No
enhancements were observed on either H-5 or H-10b upon
irradiation of the other, thus it is tentatively proposed that the
relative stereochemistry of 17c is as shown in the diagram.
The minor product (24%), a red crystalline solid, was
unambiguously identified by single crystal X-ray analysis as
the stable bicyclic azomethine ylide 18c (Fig. 1). There is
Fig. 1 X-Ray crystallographic presentation of 18c: (a) showing
monomer unit, and (b) showing water of crystallization and H-bonded
dimers.
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water of crystallization in the ylide structure. The crystal
structure contains H-bonded dimers with the water molecules
H-bonded to the keto-carbonyl oxygen atom O(2) [Fig. 1(b)].
The determination of the structure of 18c is significant since, in
as far as we can gather to-date, only a handful of azomethine
ylides have been characterised in this way.21–27 The C–N bonds
of the dipolar system differ significantly in length with the N(2)–
C(22) bond [1.443(2) A˚] being close to a typical sp3N–Csp3 bond
(1.48A˚) whilst theN(2)–C(8) bond [1.298(3) A˚] is slightly shorter
than a typical C=N double bond. These measurements suggest
strongbond localisation, a feature characteristic of those isolable
azomethine ylides for which X-ray structural analysis has been
performed.21–27 A twist angle of 64.5◦ between the planes defined
by C(8)–N(2)–C(1) and C(22)–C(23)–C(26) further testifies to
the low degree of conjugative interaction between the iminium
and the anionic functionalities of the dipolar system. The lack of
p-conjugation coupled with the non-planarity of the dipole unit
suggest a role for steric features and/or electronic interactions
at the ionic centres as the driving force(s) for stabilisation of
18c. These structural parameters also call into question the
classification of 18c as a 1,3-dipole and experiments are currently
on-going to probe this hypothesis.
Azomethine ylides are widely recognised as key intermediates
in a variety of thermal rearrangements of 4-isoxazolines;28
however, aside from when the C=N bond is part of an aromatic
system, the ylides have seldom been observed to be isolable.
Exceptions include an example where the C=Nmoiety is part of
a 3,4-dihydroisoquinoline structure29 or where the C atom of the
C=N unit bears a phenyl or styryl group.30,31 Eberbach and co-
workers have recently reported the first examples of isoxazolines
which transform to stable, isolable, azomethine ylides having
stabilising groups only at one end of the dipole.21,32 To the
best of our knowledge, compounds 18 represent a new type
of stable azomethine ylide where the C=N moiety is part of a
dihydroquinazoline ring system.
The N-1 phenyl dipole 8b reacted in a parallel fashion to
that observed for 8c and the primary cycloaddition product 17b
was isolated with the stable dipole 18b in 63 and 14% yield
respectively. It was subsequently found that smooth conversion
between 17b,c and 18b,c could be achieved upon stirring the
primary adducts in solution in MeOH.
Reaction between dipoles 8d and 8e and dimethyl acetylenedi-
carboxylate furnished only the primary cycloaddition products
17d (quantative yield) and 17e (79%). The N-1 methyl derivative
8a reacted rather differently from its aryl counterparts with
dimethyl acetylenedicarboxylate. No primary cycloaddition
products were found in the reaction mixture. 1H NMR spectral
analysis indicated the presence of one main product together
with a number of minor products. Purification by flash column
chromatography gave a pure sample of the main product, a red
crystalline solid, characterised as the stable azomethine ylide
18a (60%). A number of minor products with varying stability
were also isolated but we are not in a position to confirm their
structure.
Significantly, during the isolation of 18a a colourless crys-
talline solid fell from the early column fractions following
standing at rt, and thismaterialwas subsequently foundbyX-ray
crystal structure analysis to be the cyclopropaisoxazoloquina-
zoline 22 (5%) shown in Fig. 2. Dimethyl acetylenedicarboxylate
is known to undergo spontaneous tetramerisation33 and it may
be the case that a small amount of the tetramer was indeed
present in the starting ester – a situation previously alluded to in
the literature.34 Whilst [4 + 2]-cycloaddition of cyclopentadienes
to the dimethyl acetylenedicarboxylate tetramer have previously
been noted35 to the best of our knowledge the formation of 22
represents the first example of a [3 + 2]-cycloaddition to the
DMAD tetramer 21. Indeed, the formation of 22 represents
only the second publication of a cycloaddition reaction between
a nitrone and a cyclopropene moiety36 and only the third report
on the formation of cyclopropyl fused isoxazolidines.37
Rearrangement of 4-isoxazolines to azomethine ylides is well
knownand it is accepted thatmechanistically the transformation
proceeds in a concerted fashion by way of an acyl aziridine
intermediate. If 17 rearranges to 18 directly by way of the
aziridine 19 (Fig. 3, Path A) it is difficult to explain the relative
stability of theN-6 aryl derivatives 17b–ewith respect to theN-6
Fig. 2 X-Ray crystallographic presentation of 22.
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Fig. 3 Proposed mechanistic origin of ylides 18 from the cycloadducts 17.
methyl analogue 17a. We suggest that an alternative rearrange-
ment pathway may also operate. A two-step process, shown in
Fig. 3 (Path B), invoking 20 as a precursor to the aziridine 19
accounts for the increase in lability of the isoxazoline ring with
increasing electron releasing power on the N-6 substituent. The
proposal of the intermediary cyclopropyl fused ring skeleton 20
is in parallel with Freeman’s ring contraction mechanism for
isoxazolobenzodiazepines38
Conclusions
It has been shown that 1,2-dihydroquinazoline 3-oxides 8 are
readily prepared from o-aminoarylaldoximes and aryl aldehy-
des in a cyclocondensation reaction. For the first time this
family of heterocyclic N-oxides have been demonstrated to
have 1,3-dipolar character being trapped, under mild reaction
conditions, byN-methyl maleimide affording the diastereomeric
primary cycloadditionproducts 14–16. In reactionwithdimethyl
acetylenedicarboxylate the products comprise primary 17 and or
secondary 18 products of cycloaddition depending on the nature
of the N-1 substituent. The dipole 8a has also been trapped by
the cyclopropene moiety of the dimethyl acetylenedicarboxylate
tetramer 21.
Experimental
Melting points were determined on a Stuart Scientific (Bibby)
melting point apparatus and are uncorrected. Elemental anal-
yses were performed on a CE-440 analytical instrument. 1H
and 13C NMR spectra were recorded using a Bruker NMR
spectrometer operating at 300 MHz for 1H and 75 MHz for
13C nuclei. Data were recorded at probe temperatures with,
unless otherwise stated, tetramethylsilane as internal reference
and deuteriochloroform as solvent; J values are given in Hertz.
Flash column chromatography was carried out on silica gel 60
(0.040–0.063 nm) purchased from Merck, analytical TLC plates
were purchased from Merck, aluminium-backed and coated
with silica gel 60 F254 indicator. Samples were located by UV
illumination using a portableUVtec lamp (k = 254 nm) or by the
use of iodine staining. Mass spectra were recorded on a Profile
Kratos Analytical instrument. Infrared spectra were recorded
on a Perkin Elmer 2000 FT-IR instrument, and samples were
prepared as KBr discs.
Preparation of the 2-aminobenzaldehydes 6
The substrates 6a (1.30 g, 90%), 6b (1.70 g, 86%) and 6c
(1.40 g, 65%) were prepared by addition of the appropriate
organozinc reagent to 2,1-benzisoxazole by the method of
Baum et al. In each case the 1H NMR spectral data agree
with those published.16 4′-Methoxy-[1,1′-biphenyl]-4-yl methyl
ether 9a (0.26 g, 12%) was formed as by-product during the
preparation of 6c; the 1H NMR spectral data of isolated 9a
agree with the literature.17
4-(2-Formylanilino)benzonitrile 6d
To a solution of 4-bromobenzonitrile (3.66 g, 20 mmol) in
anhydrous THF (25 cm3) under nitrogen at −78 ◦C was added
dropwise a solution of 1.6M n-butyllithium in hexane (12.5 cm3,
20 mmol). The resulting suspension was added rapidly, via a
cannula (18 gauge double tipped needle), to a stirred slurry of
anhydrous ZnCl2 (3.41 g, 25 mmol) in THF (75 cm3) under
nitrogen at 0 ◦C. When the solution had warmed to rt, 2,1-
benzisoxazole (10 mmol) in THF (10 cm3) was added followed
by anhydrous Ni(acac)2 (1.00 g, 4 mmol) in THF (20 cm3).
Reaction progress was monitored by periodically working up
1 cm3 aliquots and observing the loss of the starting 2,1-
benzisoxazole by TLC analysis. Upon completion the reaction
was quenched with 6 M HCl (5 cm3). The reaction mixture was
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poured intowater (100 cm3) and extractedwith diethyl ether (2×
100 cm3). The ether extracts were combined, washed with water
(50 cm3) and concentrated under reduced pressure to give the
crude product. Purification by flash column chromatography
(hexane–diethyl ether; 9 : 1) afforded the pure aldehyde as a
yellow crystalline solid (1.70 g, 77%) along with [1,1′-biphenyl]-
4,4′-dicarbonitrile 9b (0.10 g, 6%). The 1H NMR spectral data
of the biphenyl agree with those reported.17
6d. Mp102–104 ◦C (fromEtOH). (Found: C, 75.13;H, 4.45;
N, 12.46. C14H10N2O requires: C, 75.68; H, 4.50; N, 12.60%). dH:
10.21 (s, 1H, NH), 9.93 (s, 1H, HC=O), 7.63 (m, 3H, Ar-H,
including 7.62, d, 2H, J 8.8, H-2′ and H-6′), 7.47 (m, 2H, Ar-H),
7.34 (d, 2H, J 8.8, H-3′ and H-5′), 7.02 (m, 1H, Ar-H). dC: 195.0
(C=O), 145.2, 144.9 (ArC–N), 137.2, 136.0, 134.0 121.3, 120.6
(Ar–CH), 120.0 (C≡N), (Ar–CH), 119.4 (ArC-CHO), 114.5
(Ar–CH), 105.9 (ArC–C≡N). IR/cm−1: m = 3424, 3108, 2844,
2764, 2219, 1659, 1595, 1529.
General procedure for the formation of 2-aminobenzaldoximes 7
A solution of the aldehyde (8 mmol), pyridine (8.1 mmol) and
NH2OH·HCl (8.1 mmol) were heated in boiling EtOH (50 cm3)
for 18 h. Following evaporation of the solvent the residue was
taken up in chloroform (50 cm3) and extracted with water
(3 × 40 cm3). The combined organic extracts were dried over
MgSO4 and concentrated to yield the crude product which was
purified by flash column chromatography or crystallization. 2-
Methoxyacridine was isolated (11%) during preparation of 7c.
2-Methylaminobenzaldehydeoxime 7a 40 and2-anilinobenzal-
dehyde oxime 7b 41 are known compounds; 1H NMR spectral
data of the prepared samples agree with published data.
2-(4-Methoxyanilono)benzaldehyde oxime 7c. White crys-
talline solid (1.62 g, 60%), mp 90–92 ◦C (from diethyl ether
and hexane). (Found: C, 68.90; H, 5.83; N, 11.35. C14H14N2O2
requires: C, 69.42; H, 5.42; N, 11.62%). dH: 8.63 (br, s, 1H,
NH/OH), 8.29 (s, 1H, HC=N), 7.16 (m, 4H, Ar-H including
d at 7.16, 2H, J 8.8, H-3′ and H-5′), 7.00 (m, 1H, Ar–H), 6.90
(d, 2H, J 8.8, H-2′ and H-6′), 6.73 (m, 1H, Ar–H), 3.82 (s, 3H,
OCH3). dC: 156.8 (ArC–O), 154.1 (HC=N), 145.9, 134.2 (ArC–
N) 133.2, 130.9, 125.9 (Ar–CH), 117.3 (ArC-2′ and 6′) 115.1
(ArC–C=NOH), 115.0, 112.9 (Ar–CH), 56.0 (OCH3).
42,43
2-Methoxyacridine. Colourless crystalline solid (0.13 g,
11%) mp 89–91 ◦C (from diethyl ether and hexane). dH: 8.56
(s, 1H, C=CH), 8.19 (d, 1H, J 8.6, Ar–H), 8.12 (d, 1H, J 8.6,
Ar–H), 7.92 (d, 1H, J 8.4, Ar–H), 7.70 (m, 1H, Ar–H), 7.48 (m,
2H, Ar–H), 7.11 (d, 1H, J 2.6, Ar–H), 3.95 (s, 3H, OMe).
4-{2-[(Hydroxyimino)methyl]anilino}benzonitrile 7d. Yellow
crystalline solid (1.00 g, 72%), mp 166–170 ◦C (from toluene).
(Found: C, 71.08; H, 4.74; N, 17.18. C14H11N3O requires: C,
70.88; H, 4.64; N, 17.72%). dH: 9.06 (br, s, 1H, NH/OH), 8.26
(s, 1H, HC=N), 7.53 (m, 2H, Ar–H), 7.44 (m, 2H, Ar–H), 7.30
(m, 2H, Ar–H), 7.21 (m, 2H, Ar–H), 6.98 (m, 1H, Ar–H). dC:
153.5 (CH=N), 146.5, 141.1 (ArC–N), 134.1, 133.3, 130.7, 121.2
(Ar–CH), 119.9, 118.9 (C≡NandArC–C=N), 118.2, 116.6 (Ar–
CH), 103.9 (ArC–C≡N). IR/cm−1: m = 3335, 2222, 1625, 1610,
1591, 1528.
1-Methyl-2-phenyl-1,2-dihydroquinazolin-3-ium-3-olate 8a
2-Methylaminobenzaldehyde oxime 7a (6.8 mmol, 1.00 g) was
stirred with benzaldehyde (34 mmol, 3.60 g) at 80 ◦C for 16 h.
Purification by flash column chromatography (diethyl ether)
afforded 8a as a green solid (1.30 g, 80%), mp 132–136 ◦C (from
diethyl ether and hexane). (Found: C, 75.61; H, 5.83; N, 11.90.
C15H14N2O requires: C, 75.63; H, 5.88; N, 11.76%). dH: 7.68 (s,
1H, HC=N), 7.35 (m, 6H, Ar–H), 7.04 (dd, 1H, J 7.6 and 1.5,
Ar–H), 6.81 (ddd, 1H, J 8.5, 8.5 and 0.9, Ar–H), 6.68 (d, 1H, J
8.2, Ar–H), 5.95 (s, 1H, H–2), 2.93 (s, 3H,Me). dC: 141.0 (C-8a),
135.5 (C-1′), 132.0 (CH=N), 131.8, 130.1, 129.2, 129.0, 128.8,
127.0, 126.4, 119.6 (Ar–CH), 116.6 (C-4a), 111.7 (Ar–CH), 86.9
(C-2), 36.1 (NMe).
1,2-Diphenyl-1,2-dihydroquinazolin-3-ium-3-olate 8b
2-Phenylaminobenzaldehyde oxime 7b (1.90 g, 9 mmol) was
stirred with benzaldehyde (4.80 g, 45 mmol) at 80 ◦C for 72 h.
Purification by flash column chromatography (diethyl ether)
afforded 8b as a yellow solid (2.10 g, 76%), mp 68–70 ◦C (from
diethyl ether and hexane). (Found: C, 75.25; H, 5.43; N, 8.44.
C20H16N2O[H2O] requires: C, 75.47; H, 5.66; N, 8.81%). dH: 7.73
(s, 1H, CH=N), 7.68 (m, 2H, Ar–H), 7.32 (m, 5H, Ar–H), 7.23
(m, 2H, Ar–H), 7.14 (m, 4H, Ar–H), 6.98 (m, 1H, Ar–H), 6.51
(s, 1H, H-2). dC: 145.1 (C-8a), 137.5 (C-1′), 135.7 (C-7′), 132.5
(CH=N), 132.5, 130.3, 130.1, 129.9, 129.6, 129.3, 128.7, 128.2,
126.6, 126.0, 124.8, 122.4, 121.9 (Ar–CH), 119.9 (C-4a), 118.8
(Ar–CH), 86.2 (C-2). IR/cm−1: m = 3436 3034, 2833, 1605, 1596,
1560, 1523, 1509, 1488, 1461.
1-(4-Methoxyphenyl)-2-phenyl-1,2-dihydroquinazolin-3-ium-3-
olate 8c
The oxime 7c (408 mg, 1.7 mmol) was stirred with benzaldehyde
(8.4 mmol, 893 mg) for 16 h at 80 ◦C. Purification by flash
column chromatography (diethyl ether) gave 8c as a yellow solid
(526 mg, 94%), mp 40 ◦C (from diethyl ether). (Found: C, 74.16;
H, 5.42;N, 7.80.C21H18N2O2[0.5H2O] requires:C, 74.33;H, 5.60;
N, 8.26%). dH: 7.71 (s, 1H,HC=N), 7.61 (m, 2H,Ar–H), 7.32 (m,
3H, Ar–H), 7.21 (m, 1H, Ar–H), 7.05 (m, 4H, Ar–H), 6.87 (m,
3H,Ar–H), 6.37 (s, 1H,CH), 3.79 (s, 3H,OCH3). dC: 157.3 (ArC–
O), 138.6, 137.9, 136.3 (Ar–C), 130.4 (Ar–CH), 130.1 (CH=N),
129.3, 128.7, 126.7, 125.9, 124.9, 121.4 (Ar–CH), 118.9 (C-4a),
117.5, 114.9 (Ar–CH), 86.6 (C-2), 55.5 (OCH3). IR/cm−1: m =
3409, 3059, 2834, 1584, 1557, 1509, 1487, 1459.
1-(4-Cyanophenyl)-2-phenyl-1,2-dihydroquinazolin-3-ium-3-
olate 8d
Theoxime 7d (152mg, 0.64mmol)was stirredwith benzaldehyde
(340mg, 3.2mmol) at 80 ◦Cfor 72h. Purificationbyflash column
chromatography afforded 8d as a white solid (93.6 mg, 45%), mp
220–225 ◦C (from diethyl ether). (Found: C, 77.09; H, 4.62; N,
12.48. C21H17N3O requires: C, 77.54; H, 4.62; N, 12.92%). dH:
7.74 (s, 1H, CH=N), 7.60 (m, 4H, Ar–H), 7.32 (m, 4H, Ar–H),
7.18 (m, 5H, Ar–H), 6.51 (s, 1H, H-2). dC: 149.3 (C-8a), 135.6
(C-1′), 134.6 (C-7′), 134.2, 130.6 (Ar–CH), 130.0 (CH=N),
129.4, 126.8, 126.6, 124.7, 121.7, 120.8, 120.4 (Ar–CH), 119.0
(C-4a and C≡N), 107.3 (C-4′), 86.1 (C-2). IR/cm−1: m = 3396,
3057, 2216, 1598, 1586, 1556, 1506, 1486.
1-(4-Methoxyphenyl)-2-(4-nitrophenyl)-1,2-dihydroquinazolin-
3-ium-3-olate 8e
The oxime 7c (1.3 mmol, 315 mg) was stirred in with 4-
nitrobenzaldehyde (980 mg, 6.6 mmol) at 120 ◦C for 4 h.
Purification by flash column chromatography (diethyl ether–
MeOH; 9.5 : 0.5) afforded 8e as a yellow solid (0.50 g, 100%),
mp 143–145 ◦C (diethyl ether and hexane). (Found: C, 66.83;
H, 4.67; N, 11.08. C21H17N3O4 requires: C, 67.20; H, 4.40; N,
11.08%). dH: 8.17 (d, 2H, J 8.7, H-9′ and H-11′), 7.86 (d, 2H,
J 8.7, H-8′ and H-11′), 7.76 (s, 1H, CH=N), 7.24 (m, 1H,
Ar–H), 7.05 (d, 2H, J 8.0, H-2′ and H-6′) 6.99 (m, 3H, Ar–
H), 6.88 (d, 2H, J 8.0, H-3′ and H-5′) 6.45 (s, 1H, 2-H), 3.81
(s, 1H, OCH3). dC: 158.0 (ArC–O), 148.9 (ArC–NO2), 143.4
(C-8a), 138.3, 138.2 (Ar–C), 131.2 (Ar–CH), 130.8 (CH=N),
128.3, 126.5, 125.1, 124.3, 122.7 (Ar–CH), 119.4 (C-4a), 118.7,
115.5 (Ar–CH), 86.4 (C-2), 56.0 (OCH3). IR/cm−1: m = 3413,
3059, 2835, 1585, 1557, 1510, 1488, 1459.
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1,2-Bis-(4-methoxyphenyl)-1,2-dihydroquinazolin-3-ium-3-
olate 8f
The oxime 7c (266 mg, 1.1 mmol) and p-methoxybenzaldehyde
(750 mg, 5.5 mmol) were heated at 80 ◦C. Reaction progress
reached its limit after 236 h (68% oxime consumption). Purifi-
cation by flash column chromatography (diethyl ether–MeOH;
9.5 : 0.5) gave 8f (192 mg, 49%) as a clear green oil. dH: 7.68 (s,
1H, CH=N), 7.52 (d, 1H, J 8.6, Ar–H), 7.18 (m, 1H, Ar–H),
7.06 (d, 2H, J 8.6, Ar–H), 7.00 (d, 1H, J 8.3, Ar–H), 6.91 (d,
1H, J 7.4, Ar–H), 6.88 (m, 4H, Ar–H), 6.30 (s, 1H, H-2), 3.80,
3.76 (2 × OCH3).
5,10-Dimethyl-6-phenyl-5,8a,11a,11b-tetrahydropyrrolo[3′,4′:
4,5]isoxazolo[2,3-c]quinazoline-9,11(6H ,10H)-diones 14a, 15a
and 16a
A solution of the nitrone 8a (0.5 g, 2.1 mmol) and N-methyl
maleimide (0.24 g, 2.1 mmol) in DCM (20 cm3) was stirred at
rt for 18 h. The solvent was removed under reduced pressure
to give the crude reaction products, the 1H NMR spectral
analysis of which indicated the presence of three diastereomeric
cycloadducts 14a, 15a and 16a in a 5 : 6 : 1 ratio. Purification
by flash column chromatography (DCM) followed by crystalli-
sation (diethyl ether and hexane) afforded pure samples of 14a
(0.257 g, 37%) and 15a (220 mg, 32%), and only a trace amount
of the minor isomer 16a was isolated.
Microanalytical data were obtained on a mixed sample
of 14a and 15a. (Found: C, 67.55; H, 5.42; N, 11.65.
C20H19O3N3[0.5H2O] requires: C, 67.03; H, 5.59; N, 11.73%).
14a. White powder, mp 220–223 ◦C (diethyl ether and
hexane). dH: 7.25 (m, 4H, Ar–H), 7.11 (m, 3H, Ar–H), 6.76 (m,
2H, Ar–H), 5.57 (s, 1H, H-6), 4.77 (d, 1H, J 7.3, H-8a), 4.50 (s,
1H, H-11b), 3.77 (d, 1H, J 7.3, H-11a), 3.07 (s, 3H, NCH3), 3.06
(s, 3H, NCH3). dC: 175.7 (C=O), 175.6 (C=O), 143.1 (C-4a),
137.4 (C-1′), 129.3, 129.2, 128.9, 127.4, 127.3 (Ar–CH), 118.2
(C-11c), 117.4, 111.2 (Ar–CH), 77.4 (C-6), 75.6 (C-8a), 59.5 (C-
11b), 56.5 (C-11a), 37.7 (NCH3), 25.5 [C(O)NCH3]. IR/cm−1:
m = 3460, 2919, 2839, 1786, 1698, 1603, 1577, 1508, 1448.
nOeds results for 14a. Irradiation of H-8a caused a 5.4%
enhancement on the signal representingH-11a; irradiation ofH-
11a caused enhancements on H-8a (7.1%) and onH-11b (3.2%);
irradiation of H-11b caused a 2.3% enhancement on H-11a.
15a. White powder, mp 220–225 ◦C (from diethyl ether and
hexane). dH: 7.53 (m, 2H, Ar–H), 7.38 (m, 3H, Ar–H), 7.24 (m,
2H, Ar–H), 6.90 (m, 2H, Ar–H), 5.22 (s, 1H, H-6), 5.12 (s, 1H,
H-11b), 4.77 (d, 1H, J 7.3, H-8a), 3.73 (d, 1H, J 7.3, H-11a),
3.02 [s, 3H, C(O)NCH3], 2.70 (s, 3H, NCH3). dC: 175.3 (C=O),
174.6 (C=O), 146.5 (C-4a), 137.0 (C-1′), 129.0 (Ar–CH), 128.6
(C-11c), 128.5, 127.3, 120.7, 119.3, 115.3 (Ar–CH), 77.9 (C-
6), 75.5 (C-8a), 65.3 (C-11b), 55.7 (C-11a), 36.9 (NCH3), 25.2
[C(O)NCH3].
nOeds results for 15a. Irradiation of H-8a caused a 7.1%
enhancement on the signal representingH-11a; irradiation ofH-
11a caused enhancements on H-8a (7.3%) and onH-11b (2.1%);
irradiation of H-11b caused a 2.5% enhancement on H-11a.
10-Methyl-5,6-diphenyl-5,8a,11a,11b-tetrahydropyrrolo[3′,4′:
4,5]isoxazolo[2,3-c]quinazoline-9,11(6H ,10H)-diones 14b, 15b
and 16b
A solution of the nitrone 8b (153 mg, 0.51 mmol) and N-methyl
maleimide (57mg, 0.51 mmol) was stirred in DCM (20 cm3) at rt
for 18 h. The solventwas removed under reduced pressure to give
the crude reaction products, the 1H NMR spectral analysis of
which indicated a mixture of three isomeric cycloadducts 14b,
15b and 16b in 2.5 : 2 : 1 ratio. Purification by flash column
chromatography (DCM) followed by crystallization (diethyl
ether and hexane) afforded 14b (119 mg, 55%), 15b (75 mg,
35%) and 16b (24 mg, 10%).
Microanalytical and mp data were obtained on a sample
of mixed diastereomers; white powder, mp 250–252 ◦C (from
diethyl ether and hexane). (Found: C, 72.38; H, 5.08; N, 10.07.
C25H21N3O3 requires: C, 72.99; H, 5.25; N, 10.50%).
14b. dH: 7.39 (m, 2H, Ar–H), 7.28 (m, 5H, Ar–H), 7.18 (m,
2H, Ar–H), 7.1 (m, 4H, Ar–H), 6.87 (m, 1H, Ar–H), 5.99 (s,
1H, H-6), 4.85 (d, 1H, J 7.2, H-9a), 4.55 (s, 1H, H-11b), 3.82
(d, 1H, J 7.2, H-11a), 3.11 (s, 3H, NCH3). dC: 175.7 (C=O),
175.6 (C=O), 148.0 (C-4a), 140.9 (C-1′), 137.9 (C-7′), 129.8,
129.2, 128.9, 128.5, 127.8, 127.6, 124.5, 123.9 (Ar–CH), 121.1
(C-11c), 120.5, 118.1 (Ar–CH), 77.9 (C-6), 75.7 (C-8a), 60.00
(C-11b), 56.4 (C-11a), 25.6 (NCH3). IR/cm−1: m = 3473, 2951,
2834, 1788, 1699, 1595, 1578, 1496.
nOeds results for 14b. Irradiation of H-8a caused a 6.1%
enhancement on the signal representingH-11a; irradiation ofH-
11a caused enhancements on H-8a (8.3%) and onH-11b (3.6%);
irradiation of H-11b caused a 3.0% enhancement on H-11a.
15b. dH: 7.35 (m, 3H, Ar–H), 7.13 (m, 5H, Ar–H), 7.00 (m,
4H, Ar–H), 6.88 (t, 1H, J 7.3, Ar–H), 6.66 (d, 1H, J 8.2, Ar–H),
5.68 (s, 1H, H-6), 5.23 (1H, s, H-11b), 4.84 (1H, d, J 7.4, H-8a),
3.74 (1H, d, J 7.4, H-11a), 3.01 (3H, s, NCH3). dC: 175.7 (C=O),
174.8 (C=O), 145.6, 144.4 (C-1′ and C-4a), 136.8 (C-7′), 130.7,
130.4, 129.4, 128.6, 128.5, 128.2, 127.8, 126.5 (Ar–CH), 120.2
(C-11c), 120.0, 117.2 (Ar–CH), 78.9 (C-6), 76.2 (C-8a), 65.8
(C-11b), 56.2 (C-11a), 25.6 (NCH3). IR/cm−1: m = 3471, 3035,
2922, 1783, 1709, 1603, 1593, 1576, 1491.
nOeds results for 15b. Irradiation of H-6 caused a 5.7%
enhancement on the signal representing H-11b; irradiation of
H-8a caused a 6.3% enhancement on the signal representing
H-11a; irradiation of H-11a caused enhancements on H-8a
(7.0%) and on H-11b (2.8%); irradiation of H-11b caused a
3.9% enhancement on H-6.
16b. dH: 7.40 (m, 2H, Ar–H), 7.29 (m, 5H, Ar–H), 7.08 (m,
6H, Ar–H), 6.75 (t, 1H, J 6.3, Ar–H), 5.95 (s, 1H, H-6), 4.97 (d,
1H, J 8.0, H-8a), 4.70 (d, 1H, J 8.0, H-11b), 4.24 (dd, 1H, J 8.0
and 8.0, H-11a), 2.63 (s, 3H, NCH3).
nOeds results for 16b. Irradiation of H-6 caused a 4.1%
enhancement on the signal representing H-11a; irradiation of
H-8a caused a 9.5% enhancement on the signal representing
H-11a; irradiation of H-11a caused enhancements on H-8a
(6.6%) and on H-11b (6.2%); irradiation of H-11b caused a
8.5% enhancement on H-11a.
5-(4-Methoxyphenyl)-10-methyl-6-phenyl-5,8a,11a,11b-
tetrahydropyrrolo[3′,4′:4,5]isoxazolo[2,3-c]quinazoline-
9,11(6H ,10H)-diones 14c, 15c and 16c
A solution of the nitrone 8c (0.30 g, 0.91 mmol) and N-methyl
maleimide (101 mg, 0.91 mmol) in DCM (20 cm3) was stirred at
rt for 18 h. The solvent was removed under reduced pressure
to give the crude reaction products, the 1H NMR spectral
analysis of which indicated the presence of a mixture of three
isomeric cycloadducts 14c, 15c and 16c in a ratio of 4.5 :
2.5 : 1. Purification by flash column chromatography (DCM)
followed by crystallisation (diethyl ether and hexane) afforded
14c (0.175 g, 46%), 15c (0.102 g, 27%) and 16c (10 mg, 3%).
Microanalytical data were obtained on a mixed sample of 14c
and 15c. (Found:C, 69.60;H, 5.38;N, 9.23. C26H23N3O4[0.5H2O]
requires: C, 69.33; H, 5.33, N, 9.33%).
14c. White powder, 190–192 ◦C (fromdiethyl ether). dH: 7.37
(m, 2H, Ar–H), 7.27 (m, 3H, Ar–H), 7.13 (m, 4H, Ar–H), 6.84
(m, 4H, Ar–H), 5.84 (s, 1H, H-6), 4.84 (d, 1H, J 7.5, H-8a), 4.53
(s, 1H, H-11b), 3.80 (d, 1H, J 7.5, H-11a), 3.79 (s, 3H, OCH3),
3.09 (s, 3H, NCH3). dC: 175.4 (C=O), 175.2 (C=O), 157.1
(C-4′), 141.7 (C-1′), 140.1, 137.9 (Ar–C), 128.8, 128.4, 128.2,
127.2, 126.8 (Ar–CH), 119.4 (C-11c), 119.0, 116.3, 114.8 (Ar–
CH), 77.7 (C-6), 75.4 (C-8a), 59.5 (C-11b), 56.1 (C-11a), 55.5
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(OCH3), 25.2 (NCH3). IR/cm−1: m = 3473, 2951, 2834, 1788,
1701, 1597, 1576, 1508, 1493.
nOeds results for 14c. Irradiation of H-8a caused a 6.4%
enhancement on the signal representing H-11a; irradiation of
H-11b caused a 2.9% enhancement on H-11a.
15c. White powder, 190–195 ◦C (fromdiethyl ether). dH: 7.38
(m, 2H, Ar–H), 7.27 (m, 1H, Ar–H), 7.14 (m, 3H, Ar–H), 7.01
(m, 1H, Ar–H), 6.93 (d, 2H, J 8.8, H-3′ and H-5′), 6.92 (m, 1H,
Ar–H), 6.66 (d, 2H, J 8.8, H-2′ and H-6′), 6.35 (d, 1H, J 8.3,
Ar–H), 5.62 (s, 1H, H-6), 5.26 (s, 1H, H-11b) 4.88 (d, 1H, J 7.2,
H-8a), 3.78 (d, 1H, J 7.2, H-11a), 3.70 (s, 3H, OCH3), 3.02 (s,
3H, NCH3).
nOeds results for 15c. Irradiation of H-6 caused a 5.6%
enhancement on the signal representing H-11b; irradiation of
H-8a caused enhancements onH-6 (2.3%) and onH-11a (6.5%);
irradiation of H-11b caused a 6.7% enhancement on H-6 and a
2.5% enhancement on H-11a.
16c. Isolated as a white powder, 190–192 ◦C (from diethyl
ether). dH: 7.39 (m, 2H, Ar–H), 7.28 (m, 3H, Ar–H), 7.12 (d,
2H, J 9.0, H-3′ and H-5′), 7.05 (m, 2H, Ar–H), 6.93 (m, 1H,
Ar–H), 6.86 (d, 2H, J 9.0, H-2′ and H-6′) 6.70 (m, 1H, Ar–H),
5.81 (s, 1H, H-6), 4.97 (d, 1H, J 8.0, H-8a), 4.67 (br, d, 1H, J
6.2, H-11b), 4.25 (br, dd, 1H, J 8.0 and 8.0, H-11a), 3.79 (s, 3H,
OCH3), 2.70 (s, 3H, NCH3).
nOeds results for 16c. Irradiation of H-8a caused a 5.6% en-
hancement on the signal representingH-11a; irradiation ofH-11a
caused enhancements on H-8a (7.8%) and on H-11b (1.2%);
irradiation of H-11b caused a 4.3% enhancement on H-11a.
4-[10-Methyl-9,11-dioxo-6-phenyl-8a,9,10,11,11a,11b-
hexahydropyrrolo[3′,4′:4,5]isoxazolo[2,3-c]quinazolin-5(6H)-
yl]benzonitriles 14d, 15d and 16d
A solution of the nitrone 8d (111 mg, 0.5 mmol) and N-methyl
maleimide (55 mg, 0.5 mmol) in DCM (10 cm3) was stirred at
rt for 18 h. The solvent was removed under reduced pressure.
1H NMR spectral analysis of the crude product indicated the
presence of three isomeric cycloadducts 14d, 15d and 16d in a
1 : 0.2 : 1 ratio. Purification by flash column chromatography
(DCM) followed by crystallization (diethyl ether and hexane)
afforded 14d (0.11 g, 50%), 16d (0.067 g, 30%) and only a trace
amount of 15d.
Microanalytical and mp data were obtained on a mixed
sample of 14d and 16d, white powder, decomposes at 270–
280 ◦C (from diethyl ether). (Found: C, 70.73; H, 4.60; N, 12.51.
C26H20N4O3[0.5H2O] requires: C, 70.11; H, 4.72; N, 12.58%).
14d. dH: 7.54 (d, 2H, J 8.3, H-3′ and H-5′), 7.26 (m, 10H,
Ar–H) 7.01 (t, 1H, J 7.7, Ar–H), 6.10 (s, 1H,H–6), 4.83 (d, 1H, J
7.3,H-8a), 4.58 (s, 1H,H-11b), 3.82 (d, 1H, J 7.3,H-11a), 3.12 (s,
3H, N–Me). dC: 175.0 (C=O), 174.7 (C=O), 152.2 (C-4a), 138.2
(C-1′), 136.0 (C-7′), 133.6, 129.1, 128.9, 128.5, 127.8, 127.0 (Ar–
CH), 122.9 (C-11c), 122.8, 121.3, 119.6 (Ar–CH), 119.2 (C≡N),
105.5 (C-4′), 77.6 (C-6), 75.2 (C-8a), 59.6 (C-11b), 56.0 (C-11a),
25.3 (NCH3). IR/cm−1: m = 3473, 3042, 2947, 2231, 1789, 1701,
1608, 1600, 1585, 1509, 1493.
nOeds results for 14d. Irradiation of H-8a caused a 6.8%
enhancement on the signal representingH-11a; irradiation ofH-
11a caused enhancements on H-8a (7.9%) and onH-11b (3.1%);
irradiation of H-11b caused a 2.7% enhancement on H-11a.
16d. dH: 7.57 (d, 2H, J 8.5, H-3′ and H-5′), 7.37 (m, 2H,
Ar–H), 7.25 (m, 7H, Ar–H, including 7.16, d, J 8.5, H-2′ and
H-6′), 7.05 (d, 1H, J 7.2, Ar–H), 6.90 (m, 1H, J 3.9, Ar–H),
6.08 (s, 1H, H-6), 4.96 (d, 1H, J 8.2, H-8a), 4.75 (d, 1H, J 8.2,
H-11b), 4.29 (dd, 1H, J 8.2 and 8.2, H-11a), 2.66 (s, 3H, NCH3).
dC: 173.0 (C=O), 172.6 (C=O), 152.2 (C-4a) 139.4 (C-1′), 136.2
(C-7′), 134.0, 129.4, 129.2, 128.9, 127.5, 122.7, 121.3 (Ar–CH),
120.7 (C-11c), 120.4 (Ar–CH), 119.6 (C≡N), 105.8 (C-4′), 79.0
(C-6), 76.8 (C-8a), 58.4 (C-11b), 55.5 (C-11a), 24.9 (NCH3).
Preparation of 10-methyl-6-(4-nitrophenyl)-5-(4-methoxyphenyl)-
5,8a,11a,11b-tetrahydropyrrolo[3′,4′:4,5]isoxazolo[2,3-
c]quinazoline-9,11(6H ,10H)-diones 14e, 15e and 16e
A solution of the nitrone 8e (161 mg, 0.43 mmol) and N-methyl
maleimide (48 mg, 0.43 mmol) in DCM (10 cm3) was stirred at
rt for 18 h. The solvent was removed under reduced pressure to
give a crude product, the 1H NMR spectral analysis of which
indicated the presence of three isomeric cycloadducts 14e, 15e
and 16e in a ratio of 5 : 1 : 1. Purification by flash column
chromatography (DCM) followed by crystallisation (diethyl
ether and hexane) afforded 14e (0.14 g, 67%), 15e (0.02 g, 10%)
and 16e (0.027 g, 13%).
Microanalytical data were obtained on a mixture of
14e, 15e and 16e. (Found: C, 63.19; H, 4.41; N, 11.44.
C26H22N4O6[0.5H2O] requires: C, 63.03; H, 4.65; N, 11.52%).
14e. Light yellow solid, decomposes at 240 ◦C (from diethyl
ether and hexane). dH: 8.15 (d, 2H, J 8.6, H-9′ and 11′), 7.60 (d,
2H, J 8.6, H-8′ and H-12′), 7.12 (m, 4H, Ar–H), 6.86 (m, 4H,
Ar–H), 5.91 (s, 1H, H–6), 4.87 (d, 1H, J 7.2, H-8a), 4.47 (s, 1H,
H-11b), 3.84 (d, 1H, J 7.2, H-11a), 3.79 (s, 3H, OCH3), 3.09
(s, 3H, NCH3). dC: 175.4, 175.2 (C=O), 157.8 (ArC–O) 148.4,
145.3, 141.4, 140.1 (Ar–C), 128.9, 128.8, 127.7, 127.2, 124.5,
120.3 (Ar–CH), 119.7 (C-11c), 117.3, 115.3 (Ar–CH), 77.6 (C-6),
75.8 (C-8a), 59.9 (C-11b), 56.5 (C-11a), 55.9 (OCH3).
nOeds results for 14e. Irradiation of H-8a caused a 6.3%
enhancement on the signal representing H-11a; irradiation of
H-11b caused a 3.6% enhancement on H-11a.
15e. Yellow solid, decomposes at 235 ◦C (from diethyl ether
and hexane). dH: 8.01 (d, 2H, J 8.6, H-9′ and H-11′), 7.59 (d,
2H, J 8.6, H-9′ and H-12′), 7.28 (m, 1H, Ar-H), 6.96 (m, 4H,
Ar-H, including d at 6.94, 2H, J 8.7, H-2′ and H-6′), 6.69 (d,
2H, J 8.7, H-3′ and 5′), 6.34 (d, 1H, J 8.3, Ar-H), 5.72 (s, 1H,
H-6), 5.30 (s, 1H, H-11b), 4.92 (d, 1H, J 7.3, H-8a), 3.84 (d,
1H, J 7.3, H-11a), 3.70 (s, 3H, OCH3), 3.02 (s, 3H, NCH3). dC:
175.5, 174.8 (C=O), 158.5 (ArC–O), 147.9, 146.0, 143.6 (Ar–C),
136.1 (C-7′), 132.1, 131.3, 128.6, 127.6, 123.4, 120.2 (Ar–CH),
119.6 (C-11c), 116.9, 115.0 (Ar–CH), 78.0 (C-6), 75.8 (C-8a),
65.6 (C-11b), 55.9 (C-11a), 55.6 (OMe), 25.6 (NMe).
16e. Isolated as a yellow crystalline solid, decomposes at
248 ◦C (from diethyl ether and hexane). dH: 8.15 (d, 2H, J 8.6,
H-9′ and H-11′), 7.59 (d, 2H, J 8.6, H-8′ and H-12′), 7.08 (m,
4H, Ar–H), 6.88 (m, 3H, Ar–H), 6.76 (m, 1H, Ar–H), 5.81 (s,
1H, H-6), 4.98 (d, 1H, J 8.1, H-8a), 4.66 (br, 1H, H-11b), 4.25
(dd, 1H, J 8.1 and 8.1, H-11a), 3.80 (s, 3H, OCH3), 2.71 (s, 3H,
NCH3). dC: 172.9, 172.9 (C=O), 157.5 (ArC–O), 148.3, 142.1,
140.0 (Ar–C), 129.4, 129.3, 128.4, 126.1, 124.3, 120.2 (Ar–CH),
118.3, 117.7 (Ar–C), 115.3 (Ar–CH), 78.8 (C-6), 77.2 (C-8a),
59.2 (C-11b), 55.9 (OCH3), 53.8 (C-11a), 25.0 (NCH3).
nOeds results for 16e. Irradiation of H-8a caused a 6.4%
enhancement on the signal representing H-11a; irradiation of
H-11b caused a 2.9% enhancement on H-11a.
Dimethyl 5,6-diphenyl-6,10b-dihydro-5H-isoxazolo[2,3-
c]quinazoline-1,2-dicarboxylate 17b and (Z)-3-(1,2-diphenyl-
1,2-dihydroquinazolin-3-ium-3-yl)-1,4-dimethoxy-1,4-dioxo-2-
buten-2-olate 18b.
A solution of the nitrone 8b (226 mg, 0.75 mmol) and DMAD
(107 mg, 0.75 mmol) was stirred in DCM (10 cm3) at rt for 18 h.
The solvent was removed under reduced pressure to give a crude
product. 1H NMR spectral analysis indicated the formation of
two new products, 17b and 18b, in a ratio of 4 : 1. Purification
by flash column chromatography (diethyl ether–hexane; 2 : 8,
followed by diethyl ether–MeOH; 99 : 1) gave pure samples of
17b (0.21 g, 63%) and 18b (0.046 g, 14%).
17b. Red amorphous solid, mp 134–136 ◦C (from
methanol). (Found: C, 70.42; H, 4.99; N, 6.38. C26H22N2O3
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requires: C, 70.58; H, 4.77; N, 6.33%). dH: 7.48 (m, 2H, Ar–
H), 7.24 (m, 11H, Ar–H), 6.77 (m, 1H, Ar–H), 6.29 (s, 1H,
H-5), 5.59 (s, 1H, H-10b), 3.80 (s, 3H, OCH3), 3.74 (s, 3H,
OCH3). dC: 163.01 (C=O), 159.40 (C=O), 152.53 (C=C–O),
148.18, 141.15 (ArC–N), 136.95 (Ar–C), 129.79, 129.06, 128.67,
128.18, 127.22 (Ar–CH), 126.48 (C-10a), 123.39, 122.01, 121.70,
119.19 (Ar–CH), 111.63 (C=C–O), 78.70 (C-5), 61.80 (C-10b),
53.38 (OCH3), 52.09 (OCH3).
18b. Red crystalline solid, mp 128–130 ◦C (from diethyl
ether and methanol). (Found: C, 66.85; H, 5.27; N, 6.17.
C26H22N2O5[1.5H2O] requires: C, 66.52; H, 5.33; N, 6.10%). dH:
8.66 (s, 1H, H-4), 7.45 (m, 6H, Ar–H), 7.30 (m, 6H, Ar–H),
7.09 (s, 1H, H-2), 6.99 (m, 2H, Ar–H), 3.83 (s, 3H, OCH3), 3.46
(OCH3). The sample was insufficiently stable upon standing in
CDCl3 to acquire 13C NMR spectral analysis.
(Z)-3-(1,2-Diphenyl-1,2-dihydroquinazolin-3-ium-3-yl)-1,4-
dimethoxy-1,4-dioxo-2-buten-2-olate 18b from 17b
A solution of 17b (0.020 g, 0.04 mmol) in MeOH (5 cm3) was
heated at reflux for 18 h. Removal of the solvent afforded the
crude product which was purified by flash column chromatog-
raphy (diethyl ether–MeOH; 99 : 1). The ylide 18c was isolated
as a red amorphous solid in 70% yield (0.007 g), and data agree
with those reported above.
(Z)-1,4-Dimethoxy-3-(1-methyl-2-phenyl-1,2-dihydroquinazolin-
3-ium-3-yl)-1,4-dioxo-2-buten-2-olate 18a and tetramethyl
3-[8a,9,9a-tris(methoxycarbonyl)-5-methyl-5,6,8a,9,9a,9b-
hexahydrocyclopropa[4,5]isoxazolo[2,3-c]quinazolin-9-yl]-7-
oxabicyclo[2.2.1]hepta-2,5-diene-1,2,5,6-tetracarboxylate 22
A solution of the nitrone 8a (888 mg, 3.7 mmol) and DMAD
(530 mg, 3.7 mmol) in DCM (30 cm3) was stirred for 18 h
at rt. The solvent was removed under reduced pressure. A 1H
NMR spectrum of the crude products indicated the presence
of a complex mixture comprising one main product together
with a number of more minor products. Purification by flash
column chromatography (diethyl ether–hexane; 1 : 1, followed
by diethyl ether–methanol; 9 : 1) gave a pure sample of themajor
product 18a (0.75 g, 60%). The cyclopropyl-fused isoxazolidine
22 (150 mg, 5%) was isolated as colourless crystals that fell out
of the first 20 column fractions.
18a. Red crystalline solid, mp 126–128 ◦C (from diethyl
ether and methanol). (Found: C, 63.55; H, 5.53; N, 7.04.
C21H20N2O5[H2O] requires: C, 63.32; H, 5.53; N, 7.04%). dH:
8.45 (s, 1H, H-4), 7.55 (m, 1H, Ar–H), 7.34 (m, 6H, Ar–H), 6.85
(t, 1H, J 7.2, Ar–H), 6.74 (s, 1H,H-2), 6.72 (d, 1H, J 8.7, Ar–H),
3.81 (s, 3H, OCH3), 3.61 (s, 3H, OCH3), 3.15 (s, 3H, NCH3). dC:
172.7 [C(O)CO2CH3], 168.4 (CO2CH3), 164.7 (CO2CH3), 161.1
(C-4), 147.0 (C-8a), 140.1 (Ar–CH), 134.5 (C-1′), 133.2, 130.6,
129.2, 126.7, 119.7 (Ar–CH), 114.8 (C-4a) 113.1 (Ar–CH) 102.2
(N+–C−), 79.2 (C-2), 52.3 (OCH3), 51.3 (OCH3), 36.9 (NCH3).
IR/cm−1: m = 3496, 3428, 3064, 2944, 1735, 1660, 1627, 1593,
1554, 1522, 1494.
22. Colourless crystalline solid characterised by X-ray crys-
tallographic analysis. (Found: C, 58.01; H, 4.94; N, 3.55.
C39H38N2O17 requires: C, 58.06; H, 4.71; N, 3.47%). dH: 7.38
(m, 2H, Ar–H), 7.28 (m, 3H, Ar–H), 7.20 (m, 2H, Ar–H), 6.76
(m, 2H, Ar–H), 5.38 (s, 1H, H-2), 5.10 (s, 1H, H-4c), 3.93, 3.91,
3.79, 3.70, 3.67, 3.53, 3.54, 3.51 (8 × OCH3).
X-Ray crystal structure determination of 22. Data were
collected at 150(2) K on a Bruker SMART 1000 diffractometer.
The structure was solved (in the centrosymmetric space group
P21/n) by direct methods and refined by full-matrix least-
squares on F 2 using the SHELXTL suite of programs.39 All
the non-hydrogen atoms were refined with anisotropic atomic
displacement parameters, and the hydrogen atoms were inserted
Table 1 Crystal data and structure refinement for 22
Identification code tomas1
Empirical formula C39H38N2O17
Formula weight 806.71
T/K 150(2)
k/A˚ 0.71073
Crystal system Monoclinic
Space group P21/n
a/A˚ 11.1011(12)
b/A˚ 21.952(2)
c/A˚ 15.9307(17)
a/◦ 90
b/◦ 103.285(2)
c /◦ 90
V/A˚3 3778.2(7)
Z 4
Dc/Mg m−3 1.418
l/mm−1 0.113
F(000) 1688
Crystal size/mm 0.43 × 0.22 × 0.03
Crystal description Colourless lath
h range for data collection/◦ 1.61 to 25.00
Index ranges −13 h 11
−16 k 26
−16 l  18
Reflections collected 18 415
Independent reflections 6642 (Rint = 0.0488)
Completeness to h = 25.00◦ (%) 99.8
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 1.000000 and 0.824622
Refinement method Full-matrix least-squares on F 2
Data/restraints/parameters 6642/0/523
Goodness-of-fit on F 2 1.010
Final R indices [I > 2r(I)] R1 = 0.0475, wR2 = 0.1027
R indices (all data) R1 = 0.0958, wR2 = 0.1226
Largest diff. peak and hole/e A˚−3 0.267 and −0.251
at calculated positions using a riding model. Details of the data
collection and structure refinement are given in Table 1.
CCDC reference number 282677. For crystallographic data
in CIF or other electronic format see DOI: 10.1039/b511998g.
Dimethyl 6-(4-methoxyphenyl)-5-phenyl-6,10b-dihydro-5H-
isoxazolo[2,3-c]quinazoline-1,2-dicarboxylate 17c and
(Z)-1,4-dimethoxy-3-[1-(4-methoxyphenyl)-2-phenyl-1,2-
dihydroquinazolin-3-ium-3-yl]-1,4-dioxo-2-buten-2-olate 18c
A solution of the nitrone 8c (0.846 g, 2.6 mmol) and DMAD
(0.365 g, 2.6 mmol) in DCM (20 cm3) was stirred at rt for 18 h.
The solvent was removed under reduced pressure to give the
crude reaction products, the 1HNMR spectral analysis of which
indicated the formation of two new products, 17c and 18c, in a
ratio of 4 : 1. Trace amounts of other undetermined products
were also evident. Purification by flash column chromatography
(diethyl ether–hexane; 1 : 1, followed by diethyl ether–MeOH;
9 : 1) gave pure samples of 17c (449 mg, 32%) and 18c
(278 mg, 24%). The structure of the latter is confirmed by X-ray
crystallographic analysis (see below).
17c. Red powder, mp 109–112 ◦C (from diethyl ether and
hexane). (Found: C, 68.31; H, 5.15; N, 5.90. C27H22N2O5
requires: C, 68.64; H, 5.08; N, 5.93%). dH: 7.50 (m, 2H, Ar–
H), 7.24 (m, 6H, Ar–H) 7.16 (d, 2H, J 8.9, H-2′ and H-6′),
7.04 (m, 1H, Ar–H), 6.85 (d, 2H, J 8.9, H-3′ and H-5′), 6.73
(m, 1H, Ar–H), 6.16 (s, 1H, H-5), 5.55 (s, 1H, H-10b), 3.84 (s,
3H, OCH3), 3.80 (s, 3H, OCH3), 3.75 (s, 3H, OCH3). dC: 163.1
(C=O), 159.6 (C=O), 156.5 (ArC–OCH3) 152.5, 141.9, 141.2
(2 × ArC–N and C=C–O) 137.1 (C-7′), 129.1, 128.7, 128.3,
127.0 (Ar–CH), 125.5 (C-10a), 124.7, 120.9, 118.9, 115.1 (Ar–
CH), 111.9 (C=C–O), 78.8 (C-5), 61.4 (C-10b), 55.9 (OCH3),
53.6 (OCH3), 52.3 (OCH3).
18c. Red crystalline solid. (Found:C, 66.43;H, 5.19;N, 5.62.
C27H22N2O5[H2O] requires: C, 66.12; H, 5.31; N, 5.71%). dH:
8.57 (s, 1H, CH=N), 7.45 (m, 4H, Ar–H), 7.25 (m, 4H, Ar–H),
O r g . B i o m o l . C h e m . , 2 0 0 5 , 3 , 4 3 5 1 – 4 3 6 1 4 3 5 9
D
ow
nl
oa
de
d 
by
 N
U
I M
ay
no
ot
h 
on
 0
9/
04
/2
01
3 
10
:2
0:
24
. 
Pu
bl
ish
ed
 o
n 
16
 N
ov
em
be
r 2
00
5 
on
 h
ttp
://
pu
bs
.rs
c.o
rg
 | d
oi:
10.
103
9/B
511
998
G
View Article Online
6.93 (m, 4H, 3 × Ar–H, H-2), 6.81 (d, 1H, J 8.1, Ar–H), 3.82
(s, 3H, OCH3), 3.81 (s, 3H, OCH3), 3.52 (s, 3H, OCH3). dC:
172.9 [C(O)CO2CH3], 168.4 (CO2CH3), 164.6 (COCH3), 159.3
(ArC–OCH3), 158.7 (C-4), 145.7 (C-8a), 138.6 (Ar–CH), 135.7,
135.6 (C-1′ and C-7′), 132.4, 130.2, 129.0, 128.2, 127.3, 121.0,
116.9 (Ar–CH), 116.6 (C-4a), 115.7 (Ar–CH), 103.3 (N+–C−),
80.0 (C-2), 55.6, 52.4, 51.1 (3 × OCH3).
X-Ray crystal structure determination of 18c. Single crystals
were analyzed using a Nonius Kappa CCD diffractometer.
Details of the data collection, solutions, and refinements are
given in Table 2. The model was solved and subsequently refined
using full-matrix least-squares in SHELXL-97.44
CCDC reference number 282676. For crystallographic data
in CIF or other electronic format see DOI: 10.1039/b511998g.
(Z)-1,4-Dimethoxy-3-[1-(4-methoxyphenyl)-2-phenyl-1,2-
dihydroquinazolin-3-ium-3-yl]-1,4-dioxo-2-buten-2-olate 18c
from 17c
A solution of 17c (0.020 g, 0.04 mmol) in MeOH (10 cm3) was
stirred at rt for 18 h. Removal of the solvent afforded the crude
product which was purified by flash column chromatography
(diethyl ether–MeOH; 99 : 1). The ylide 18cwas isolated as a red
amorphous solid in 50% yield (0.010 g); data agree with those
reported above.
Dimethyl 6-(4-cyanophenyl)-5-phenyl-6,10b-dihydro-5H-
isoxazolo[2,3-c]quinazoline-1,2-dicarboxylate 17d
The nitrone 8d (0.267 g, 0.82 mmol) and DMAD (117 mg,
0.82 mmol) were stirred in DCM (10 cm3) at rt for 18 h. The
solvent was removed under reduced pressure to leave a red solid,
the 1HNMR spectrum of which revealed the presence of a single
product, 8d which was purified by crystallization.
17d. Red amorphous solid (0.384g, 100%), mp 78–83 ◦C
(from diethyl ether and hexane). (Found: C, 66.75; H, 4.72; N,
8.63. C27H21N3O5[H2O] requires: C, 66.80; H, 4.74; N, 8.66%).
Table 2 Crystal data and structure refinement for 18c
Identification code k04pma2
Empirical formula C27H26N2O7
Formula weight 490.50
T/K 150(2)
k/A˚ 0.71073
Crystal system Triclinic
Space group P1¯
a/A˚ 11.2500(2)
b/A˚ 11.2910(2)
c/A˚ 11.7080(2)
a/◦ 76.459(1)
b/◦ 64.710(1)
c /◦ 64.809(1)
V/A˚3 1214.28(4)
Z 2
Dc/Mg m−3 1.342
l/mm−1 0.098
F(000) 516
Crystal size/mm 0.20 × 0.15 × 0.15
h range for data collection/◦ 3.72 to 27.53
Index ranges −14 h 14
−14 k 14
−15 l  15
Reflections collected 21 369
Independent reflections 5534 (Rint = 0.0399)
Reflections observed (>2r) 4325
Data completeness 0.987
Absorption correction None
Refinement method Full-matrix least-squares on F 2
Data/restraints/parameters 5534/3/335
Goodness-of-fit on F 2 1.028
Final R indices [I > 2r(I)] R1 = 0.0634, wR2 = 0.1751
R indices (all data) R1 = 0.0837, wR2 = 0.1938
Largest diff. peak and hole/e A˚−3 0.672 and −0.480
dH: 7.57 (d, 2H, J 8.7, H-9′ and H-11′), 7.45 (m, 2H, Ar–H),
7.24 (m, 8H, Ar–H), 6.90 (dd, 1H, J 6.5 and 6.5, H-4′), 6.43 (s,
1H, H-5), 5.67 (s, 1H, H-10b), 3.80 (s, 3H, OCH3), 3.74 (s, 3H,
OCH3).
Preparation of dimethyl 6-(4-methoxyphenyl)-5-(4-nitrophenyl)-
6,10b-dihydro-5H-isoxazolo[2,3-c]quinazoline-1,2-
dicarboxylate 17e
A solution of the nitrone 8e (107 mg, 0.29 mmol) and DMAD
(41 mg, 0.29 mmol) in DCM (10 cm3) was stirred at rt for 18 h.
The solvent was removed under reduced pressure. A 1H NMR
spectrum of the crude product revealed the presence of only
one product, the cycloadduct 17e. Purification by flash column
chromatography (diethyl ether–hexane; 1 : 1) provided a pure
sample of 17e (118 mg, 79%).
17e. Red amorphous solid, decomposes at 220 ◦C (from
diethyl ether and hexane). (Found: C, 61.67; H, 4.47; N, 7.72.
C27H23N3O8[0.5H2O] requires: C, 61.60; H, 4.56; N, 7.98%). dH:
8.14 (d, 2H, J 8.6, H-3′ and H-5′), 7.71 (d, 2H, J 8.6, H-2′ and
H-6′), 7.23 (m, 1H, Ar–H), 7.13 (d, 2H, J 8.8, H-7′ and H-11′),
7.06 (m, 2H, Ar–H), 6.87 (d, 2H, J 8.8, H-8′ and H-10′), 6.78
(m, 1H, Ar–H), 6.19 (s, 1H, H-5), 5.55 (s, 1H, H-10b), 3.84 (s,
3H, OCH3), 3.81 (s, 3H, OCH3), 3.75 (s, 1H, OCH3). dC: 160.1,
159.3 (CO2CH3), 156.83 (ArC–OCH3), 148.29, 144.66, 141.50,
140.90 (3 × ArC–N and C=C–O), 129.44, 129.16 (C-1′ and Ar–
CH) 127.28 (Ar–CH), 125.51 (C-10a), 124.51, 124.30, 121.65,
119.67, 115.32, 117.71 (Ar–CH), 111.80 (C=C–O) 78.54 (C-5)
61.79 (C-10b), 55.94, 53.65, 52.33 (OCH3).
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